Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase 1 2Phase 3 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Mycoses 1Leukemia 1Hematologic Neoplasms 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × posaconazole × Clear all
NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT00936117 2019-02-27

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Mycoses, Bone Marrow Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡